ID   KGP2_HUMAN              Reviewed;         762 AA.
AC   Q13237; B4DMX3; E7EPE6; O00125; O60916;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-OCT-2022, entry version 193.
DE   RecName: Full=cGMP-dependent protein kinase 2;
DE            Short=cGK 2;
DE            Short=cGK2;
DE            EC=2.7.11.12;
DE   AltName: Full=cGMP-dependent protein kinase II;
DE            Short=cGKII;
GN   Name=PRKG2; Synonyms=PRKGR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8607838; DOI=10.1006/bbrc.1996.0477;
RA   Orstavik S., Solberg R., Taskn K., Nordahl M., Altherr M.R., Hansson V.,
RA   Jahnsen T., Sandberg M.;
RT   "Molecular cloning, cDNA structure, and chromosomal localization of the
RT   human type II cGMP-dependent protein kinase.";
RL   Biochem. Biophys. Res. Commun. 220:759-765(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7498513; DOI=10.1016/0014-5793(95)01223-2;
RA   Fujii M., Ogata T., Takahashi E., Yamada K., Nakabayashi K., Oishi M.,
RA   Ayusawa D.;
RT   "Expression of the human cGMP-dependent protein kinase II gene is lost upon
RT   introduction of SV40 T antigen or immortalization in human cells.";
RL   FEBS Lett. 375:263-267(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-734.
RX   PubMed=9535793; DOI=10.1006/bbrc.1998.8399;
RA   Witczak O., Orstavik S., Natarajan V., Frengen E., Jahnsen T., Sandberg M.;
RT   "Characterization of the gene encoding the human type II cGMP-dependent
RT   protein kinase.";
RL   Biochem. Biophys. Res. Commun. 245:113-119(1998).
RN   [6]
RP   MYRISTOYLATION AT GLY-2, AND SUBCELLULAR LOCATION.
RX   PubMed=8636133; DOI=10.1074/jbc.271.12.7025;
RA   Vaandrager A.B., Ehlert E.M., Jarchau T., Lohmann S.M., de Jonge H.R.;
RT   "N-terminal myristoylation is required for membrane localization of cGMP-
RT   dependent protein kinase type II.";
RL   J. Biol. Chem. 271:7025-7029(1996).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-106 AND ARG-716.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [9]
RP   INVOLVEMENT IN SMDP, INVOLVEMENT IN AMD4, VARIANT AMD4 569-ARG--PHE-762
RP   DEL, AND CHARACTERIZATION OF VARIANT AMD4 569-ARG--PHE-762 DEL.
RX   PubMed=34782440; DOI=10.1136/jmedgenet-2021-108027;
RG   Genomics England Research Consortium;
RA   Pagnamenta A.T., Diaz-Gonzalez F., Banos-Pinero B., Ferla M.P., Toosi M.B.,
RA   Calder A.D., Karimiani E.G., Doosti M., Wainwright A., Wordsworth P.,
RA   Bailey K., Ejeskaer K., Lester T., Maroofian R., Heath K.E., Tajsharghi H.,
RA   Shears D., Taylor J.C.;
RT   "Variable skeletal phenotypes associated with biallelic variants in
RT   PRKG2.";
RL   J. Med. Genet. 0:0-0(2021).
RN   [10]
RP   VARIANT AMD4 569-ARG--PHE-762 DEL, CHARACTERIZATION OF VARIANT AMD4
RP   569-ARG--PHE-762 DEL, AND FUNCTION.
RX   PubMed=33106379; DOI=10.1136/jmedgenet-2020-107177;
RA   Diaz-Gonzalez F., Wadhwa S., Rodriguez-Zabala M., Kumar S., Aza-Carmona M.,
RA   Sentchordi-Montane L., Alonso M., Ahmad I., Zahra S., Kumar D., Kushwah N.,
RA   Shamim U., Sait H., Kapoor S., Roldan B., Nishimura G., Offiah A.C.,
RA   Faruq M., Heath K.E.;
RT   "Biallelic cGMP-dependent type II protein kinase gene (PRKG2) variants
RT   cause a novel acromesomelic dysplasia.";
RL   J. Med. Genet. 59:28-38(2022).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 137-418 IN COMPLEX WITH CAMP AND
RP   CGMP, ACTIVITY REGULATION, AND MUTAGENESIS OF ASP-412 AND ARG-415.
RX   PubMed=26769964; DOI=10.1074/jbc.m115.691303;
RA   Campbell J.C., Kim J.J., Li K.Y., Huang G.Y., Reger A.S., Matsuda S.,
RA   Sankaran B., Link T.M., Yuasa K., Ladbury J.E., Casteel D.E., Kim C.;
RT   "Structural basis of cyclic nucleotide selectivity in cGMP-dependent
RT   protein kinase II.";
RL   J. Biol. Chem. 291:5623-5633(2016).
CC   -!- FUNCTION: Crucial regulator of intestinal secretion and bone growth.
CC       Phosphorylates and activates CFTR on the plasma membrane. Plays a key
CC       role in intestinal secretion by regulating cGMP-dependent translocation
CC       of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to
CC       activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and
CC       increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By
CC       similarity). Acts as regulator of gene expression and activator of the
CC       extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in
CC       mechanically stimulated osteoblasts. Under fluid shear stress, mediates
CC       ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2
CC       and FOSB that play a key role in the osteoblast anabolic response to
CC       mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410,
CC       ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.12;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.12;
CC   -!- ACTIVITY REGULATION: Binding of cGMP results in enzyme activation.
CC       {ECO:0000269|PubMed:26769964}.
CC   -!- SUBUNIT: Interacts with GRIA1/GLUR1. {ECO:0000250|UniProtKB:Q64595}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:8636133}; Lipid-anchor
CC       {ECO:0000269|PubMed:8636133}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13237-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13237-2; Sequence=VSP_055121;
CC   -!- TISSUE SPECIFICITY: Highly concentrated in brain, lung and intestinal
CC       mucosa.
CC   -!- PTM: Myristoylation mediates membrane localization.
CC       {ECO:0000269|PubMed:8636133}.
CC   -!- DISEASE: Spondylometaphyseal dysplasia, Pagnamenta type (SMDP)
CC       [MIM:619638]: A form of spondylometaphyseal dysplasia, a group of short
CC       stature disorders distinguished by abnormalities in the vertebrae and
CC       the metaphyses of the tubular bones. SMDP is an autosomal recessive
CC       form characterized by short stature and mild platyspondyly with no
CC       disproportion between the limbs. Mild metaphyseal changes are present.
CC       {ECO:0000269|PubMed:34782440}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Acromesomelic dysplasia 4 (AMD4) [MIM:619636]: A form of
CC       acromesomelic dysplasia, a skeletal disorder characterized by short
CC       stature, very short limbs and hand/foot malformations. The severity of
CC       limb abnormalities increases from proximal to distal with profoundly
CC       affected hands and feet showing brachydactyly and/or rudimentary
CC       fingers (knob-like fingers). AMD4 radiographic hallmarks include mild
CC       to moderate platyspondyly, moderate brachydactyly, iliac flaring, and
CC       metaphyseal alterations of the long bones that progressively increase
CC       with age. AMD4 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:33106379, ECO:0000269|PubMed:34782440}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cGMP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X94612; CAA64318.1; -; mRNA.
DR   EMBL; D70899; BAA18934.1; -; mRNA.
DR   EMBL; AK297673; BAG60035.1; -; mRNA.
DR   EMBL; AC098819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139722; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Y16106; CAA76073.1; -; Genomic_DNA.
DR   EMBL; Y16107; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16108; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16109; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16110; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16111; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16112; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16113; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16114; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16115; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16116; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16117; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16118; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16119; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16120; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16121; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16122; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16123; CAA76073.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS3589.1; -. [Q13237-1]
DR   CCDS; CCDS64005.1; -. [Q13237-2]
DR   PIR; S68217; S68217.
DR   RefSeq; NP_001269409.1; NM_001282480.1.
DR   RefSeq; NP_001269410.1; NM_001282481.1.
DR   RefSeq; NP_001269411.1; NM_001282482.1.
DR   RefSeq; NP_001269412.1; NM_001282483.1.
DR   RefSeq; NP_001269414.1; NM_001282485.1. [Q13237-2]
DR   RefSeq; NP_006250.1; NM_006259.2. [Q13237-1]
DR   RefSeq; XP_005263183.1; XM_005263126.3.
DR   PDB; 5BV6; X-ray; 1.94 A; A=269-418.
DR   PDB; 5C6C; X-ray; 2.05 A; A/B=137-277.
DR   PDB; 5C8W; X-ray; 1.80 A; A/B/C/D/E/F=137-277.
DR   PDB; 5JIX; X-ray; 1.47 A; A=269-418.
DR   PDB; 5JIZ; X-ray; 1.50 A; A=269-418.
DR   PDB; 6BQ8; Other; 2.00 A; A=269-418.
DR   PDBsum; 5BV6; -.
DR   PDBsum; 5C6C; -.
DR   PDBsum; 5C8W; -.
DR   PDBsum; 5JIX; -.
DR   PDBsum; 5JIZ; -.
DR   PDBsum; 6BQ8; -.
DR   AlphaFoldDB; Q13237; -.
DR   SMR; Q13237; -.
DR   BioGRID; 111579; 10.
DR   IntAct; Q13237; 4.
DR   STRING; 9606.ENSP00000264399; -.
DR   BindingDB; Q13237; -.
DR   ChEMBL; CHEMBL2896; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q13237; -.
DR   GuidetoPHARMACOLOGY; 1493; -.
DR   iPTMnet; Q13237; -.
DR   PhosphoSitePlus; Q13237; -.
DR   BioMuta; PRKG2; -.
DR   DMDM; 6226833; -.
DR   jPOST; Q13237; -.
DR   MassIVE; Q13237; -.
DR   PaxDb; Q13237; -.
DR   PeptideAtlas; Q13237; -.
DR   PRIDE; Q13237; -.
DR   ProteomicsDB; 17341; -.
DR   ProteomicsDB; 59241; -. [Q13237-1]
DR   Antibodypedia; 1102; 257 antibodies from 30 providers.
DR   DNASU; 5593; -.
DR   Ensembl; ENST00000264399.6; ENSP00000264399.1; ENSG00000138669.10. [Q13237-1]
DR   Ensembl; ENST00000395578.3; ENSP00000378945.1; ENSG00000138669.10. [Q13237-1]
DR   Ensembl; ENST00000628926.1; ENSP00000486129.1; ENSG00000138669.10. [Q13237-2]
DR   GeneID; 5593; -.
DR   KEGG; hsa:5593; -.
DR   MANE-Select; ENST00000264399.6; ENSP00000264399.1; NM_006259.3; NP_006250.1.
DR   UCSC; uc003hmh.3; human. [Q13237-1]
DR   CTD; 5593; -.
DR   DisGeNET; 5593; -.
DR   GeneCards; PRKG2; -.
DR   HGNC; HGNC:9416; PRKG2.
DR   HPA; ENSG00000138669; Tissue enhanced (intestine, prostate).
DR   MalaCards; PRKG2; -.
DR   MIM; 601591; gene.
DR   MIM; 619636; phenotype.
DR   MIM; 619638; phenotype.
DR   neXtProt; NX_Q13237; -.
DR   OpenTargets; ENSG00000138669; -.
DR   PharmGKB; PA33778; -.
DR   VEuPathDB; HostDB:ENSG00000138669; -.
DR   eggNOG; KOG0614; Eukaryota.
DR   GeneTree; ENSGT00940000159393; -.
DR   HOGENOM; CLU_000288_73_2_1; -.
DR   InParanoid; Q13237; -.
DR   OMA; SKNPDGH; -.
DR   OrthoDB; 401933at2759; -.
DR   PhylomeDB; Q13237; -.
DR   TreeFam; TF313261; -.
DR   BRENDA; 2.7.11.12; 2681.
DR   PathwayCommons; Q13237; -.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-418457; cGMP effects.
DR   Reactome; R-HSA-9648002; RAS processing.
DR   SignaLink; Q13237; -.
DR   SIGNOR; Q13237; -.
DR   BioGRID-ORCS; 5593; 14 hits in 1100 CRISPR screens.
DR   ChiTaRS; PRKG2; human.
DR   GenomeRNAi; 5593; -.
DR   Pharos; Q13237; Tchem.
DR   PRO; PR:Q13237; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q13237; protein.
DR   Bgee; ENSG00000138669; Expressed in jejunal mucosa and 110 other tissues.
DR   ExpressionAtlas; Q13237; baseline and differential.
DR   Genevisible; Q13237; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004692; F:cGMP-dependent protein kinase activity; IMP:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; IMP:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IMP:UniProtKB.
DR   GO; GO:2001226; P:negative regulation of chloride transport; IEA:Ensembl.
DR   GO; GO:1902731; P:negative regulation of chondrocyte proliferation; IEA:Ensembl.
DR   GO; GO:0036289; P:peptidyl-serine autophosphorylation; IEA:Ensembl.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; IMP:UniProtKB.
DR   GO; GO:0046146; P:tetrahydrobiopterin metabolic process; TAS:Reactome.
DR   CDD; cd00038; CAP_ED; 2.
DR   CDD; cd05572; STKc_cGK; 1.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR002374; cGMP_dep_kinase.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR018490; cNMP-bd_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR035014; STKc_cGK.
DR   Pfam; PF00027; cNMP_binding; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000559; cGMP-dep_kinase; 1.
DR   PRINTS; PR00104; CGMPKINASE.
DR   SMART; SM00100; cNMP; 2.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF51206; SSF51206; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 2.
DR   PROSITE; PS00889; CNMP_BINDING_2; 2.
DR   PROSITE; PS50042; CNMP_BINDING_3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane; cGMP;
KW   cGMP-binding; Coiled coil; Disease variant; Dwarfism; Kinase; Lipoprotein;
KW   Membrane; Myristate; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:8636133"
FT   CHAIN           2..762
FT                   /note="cGMP-dependent protein kinase 2"
FT                   /id="PRO_0000086123"
FT   DOMAIN          453..711
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          712..762
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          117..138
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          168..283
FT                   /note="cGMP-binding, high affinity; cAMP-binding, moderate
FT                   affinity"
FT                   /evidence="ECO:0000305|PubMed:26769964"
FT   REGION          286..416
FT                   /note="cGMP-binding, high affinity; cAMP-binding, low
FT                   affinity"
FT                   /evidence="ECO:0000305|PubMed:26769964"
FT   REGION          740..762
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          23..85
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        576
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         232..235
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0007744|PDB:5C6C"
FT   BINDING         232..235
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0007744|PDB:5C8W"
FT   BINDING         242..243
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0007744|PDB:5C6C"
FT   BINDING         242..243
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0007744|PDB:5C8W"
FT   BINDING         347
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0000312|PDB:5BV6"
FT   BINDING         356..359
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0007744|PDB:5BV6"
FT   BINDING         366..367
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0007744|PDB:5BV6"
FT   BINDING         412
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0000312|PDB:5BV6"
FT   BINDING         415
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:26769964,
FT                   ECO:0000312|PDB:5BV6"
FT   BINDING         459..467
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         482
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64595"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64595"
FT   MOD_RES         431
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64595"
FT   MOD_RES         609
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61410"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:8636133"
FT   VAR_SEQ         441..469
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055121"
FT   VARIANT         22
FT                   /note="T -> S (in dbSNP:rs34956759)"
FT                   /id="VAR_051633"
FT   VARIANT         106
FT                   /note="H -> R (in dbSNP:rs34616910)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040608"
FT   VARIANT         569..762
FT                   /note="Missing (in AMD4; decreased protein abundance;
FT                   unable to phosphorylate RAF1 in response to FGF2 and to
FT                   inhibit FGF2-induced MAPK signaling; unable to suppress
FT                   SOX9-induced COL2A1 expression; unable to upregulate
FT                   COL10A1)"
FT                   /id="VAR_086537"
FT   VARIANT         716
FT                   /note="W -> R (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040609"
FT   MUTAGEN         412
FT                   /note="D->A: Reduces cGMP binding affinity; when associated
FT                   with A-415."
FT                   /evidence="ECO:0000269|PubMed:26769964"
FT   MUTAGEN         415
FT                   /note="R->A: Reduces cGMP binding affinity; when associated
FT                   with A-412."
FT                   /evidence="ECO:0000269|PubMed:26769964"
FT   CONFLICT        57..58
FT                   /note="QL -> HG (in Ref. 2; BAA18934)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154
FT                   /note="S -> I (in Ref. 5; CAA76073)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="N -> D (in Ref. 3; BAG60035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        460
FT                   /note="G -> A (in Ref. 2; BAA18934)"
FT                   /evidence="ECO:0000305"
FT   HELIX           153..164
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   HELIX           169..171
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   HELIX           174..183
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          185..189
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          194..196
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          204..211
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          213..217
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          220..224
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   HELIX           233..238
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          243..250
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   STRAND          252..258
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   HELIX           259..266
FT                   /evidence="ECO:0007829|PDB:5C8W"
FT   HELIX           270..282
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   HELIX           285..287
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   HELIX           292..301
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   STRAND          303..307
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   STRAND          312..314
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   STRAND          323..335
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   STRAND          344..350
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   HELIX           357..362
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   STRAND          368..372
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   STRAND          377..382
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   HELIX           384..389
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   HELIX           391..393
FT                   /evidence="ECO:0007829|PDB:5JIX"
FT   HELIX           395..414
FT                   /evidence="ECO:0007829|PDB:5JIX"
SQ   SEQUENCE   762 AA;  87432 MW;  FA7BA149906B5996 CRC64;
     MGNGSVKPKH SKHPDGHSGN LTTDALRNKV TELERELRRK DAEIQEREYH LKELREQLSK
     QTVAIAELTE ELQNKCIQLN KLQDVVHMQG GSPLQASPDK VPLEVHRKTS GLVSLHSRRG
     AKAGVSAEPT TRTYDLNKPP EFSFEKARVR KDSSEKKLIT DALNKNQFLK RLDPQQIKDM
     VECMYGRNYQ QGSYIIKQGE PGNHIFVLAE GRLEVFQGEK LLSSIPMWTT FGELAILYNC
     TRTASVKAIT NVKTWALDRE VFQNIMRRTA QARDEQYRNF LRSVSLLKNL PEDKLTKIID
     CLEVEYYDKG DYIIREGEEG STFFILAKGK VKVTQSTEGH DQPQLIKTLQ KGEYFGEKAL
     ISDDVRSANI IAEENDVACL VIDRETFNQT VGTFEELQKY LEGYVANLNR DDEKRHAKRS
     MSNWKLSKAL SLEMIQLKEK VARFSSSSPF QNLEIIATLG VGGFGRVELV KVKNENVAFA
     MKCIRKKHIV DTKQQEHVYS EKRILEELCS PFIVKLYRTF KDNKYVYMLL EACLGGELWS
     ILRDRGSFDE PTSKFCVACV TEAFDYLHRL GIIYRDLKPE NLILDAEGYL KLVDFGFAKK
     IGSGQKTWTF CGTPEYVAPE VILNKGHDFS VDFWSLGILV YELLTGNPPF SGVDQMMTYN
     LILKGIEKMD FPRKITRRPE DLIRRLCRQN PTERLGNLKN GINDIKKHRW LNGFNWEGLK
     ARSLPSPLQR ELKGPIDHSY FDKYPPEKGM PPDELSGWDK DF
//
